Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
XOMA Receives $4 Million for Sale of Royalty Interest in CIMZIA(R)
August 18, 2010
from GlobeNewswire News Releases
XOMA Announces Reverse Stock Split
August 17, 2010
from GlobeNewswire News Releases
XOMA Reports Second Quarter 2010 Financial Results
August 09, 2010
from GlobeNewswire News Releases
Liberty Analytics Co. Initiates Independent Research Coverage on XOMA Ltd.
August 05, 2010
from GlobeNewswire News Releases
XOMA 052 Designated Orphan Drug by FDA for Treatment of Behcet's Disease
August 04, 2010
from GlobeNewswire News Releases
XOMA to Announce 2010 Second Quarter Financial Results and Host Webcast Conference Call on August 9, 2010
August 02, 2010
from GlobeNewswire News Releases
XOMA 052 Orphan Drug Designation for Behcet's Disease Recommended by European Medicines Agency
July 29, 2010
from GlobeNewswire News Releases
XOMA Receives $750,000 Milestone Payment From AVEO Pharmaceuticals
July 26, 2010
from GlobeNewswire News Releases
XOMA Enters Into $30 Million Committed Equity Financing Facility
July 23, 2010
from GlobeNewswire News Releases
XOMA Achieves Planned Enrollment Goal for Phase 2b Clinical Trial of XOMA 052 in Type 2 Diabetes
June 30, 2010
from GlobeNewswire News Releases
Preclinical Results With XOMA 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions
June 26, 2010
from GlobeNewswire News Releases
Journal Article in Endocrinology Highlights Preclinical XOMA 052 Data in Type 2 Diabetes
June 22, 2010
Company Will Present Two Posters at 2010 American Diabetes Association Scientific Sessions Read More
from GlobeNewswire News Releases
Positive Clinical Findings Presented on XOMA 052 in Debilitating Eye Disease
June 17, 2010
Results of Pilot Study in Patients With Uveitis of Behcet's Disease Presented at EULAR Read More
from GlobeNewswire News Releases
NASDAQ Grants XOMA's Request for Continued Listing
June 15, 2010
from GlobeNewswire News Releases
XOMA to Host Conference Call to Present Initial Results From XOMA 052 Clinical Trial in Behcet's Disease
June 10, 2010
from GlobeNewswire News Releases
Abstract Published on Initial Results From XOMA 052 Clinical Trial in Behcet's Disease
May 12, 2010
from GlobeNewswire News Releases
XOMA Reports First Quarter 2010 Financial Results
May 06, 2010
from GlobeNewswire News Releases
XOMA 052 Mechanism of Action Results Published in Journal of Biological Chemistry
April 30, 2010
from GlobeNewswire News Releases
XOMA to Announce 2010 First Quarter Financial Results and Host Webcast Conference Call on May 6
April 29, 2010
from GlobeNewswire News Releases
XOMA 052 Shows Potent In Vitro Inhibition of Interleukin-6 Production in Human Myeloma Cells
April 19, 2010
from GlobeNewswire News Releases
XOMA Receives $1 Million Milestone Payment From Takeda Pharmaceutical
April 15, 2010
from GlobeNewswire News Releases
XOMA Issued Two New U.S. Patents for Methods of Treating Type 2 Diabetes and Inflammatory Diseases Using Interleukin-1 Beta Antibodies
April 13, 2010
Key Additions to XOMA's Intellectual Property Portfolio for Its Lead Proprietary Product Candidate Which May Have Broad Commercial Utility in Multiple Disease Areas Read More
from GlobeNewswire News Releases
Data on XOMA 052 to be Presented at the American Association of Cancer Research Annual Meeting
April 09, 2010
from GlobeNewswire News Releases
Bedfordreport.com: Complimentary Analyst Research on Motorola, Inc. (NYSE: MOT), XOMA, Ltd. (Nasdaq: XOMA), General Electric Co. (NYSE: GE), Google, Inc. (Nasdaq: GOOG) and Many More
March 17, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report. Read More
from Marketwired News Releases
XOMA Receives Anticipated Notice of Non-Compliance From NASDAQ
March 16, 2010
from GlobeNewswire News Releases
XOMA 052 Prevents Adverse Cardiac Remodeling in Animal Model of Heart Attack
March 14, 2010
from GlobeNewswire News Releases
XOMA 052 Phase 2 Trial Initiated in Type 1 Diabetes Patients
March 12, 2010
from GlobeNewswire News Releases
XOMA Reports 2009 and Fourth Quarter Financial Results
March 11, 2010
from GlobeNewswire News Releases
XOMA to Announce 2009 and Fourth Quarter Financial Results and Host Conference Call on March 11
March 04, 2010
from GlobeNewswire News Releases
XOMA to Webcast Presentations From Two March 2010 Investment Conferences
February 25, 2010
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here